Dr. Harin Haridas Kanani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 0.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Limited, has disclosed the creation of a pledge/encumbrance on 13,19,083 equity shares held by him on March 30, 2026. This disclosure is filed under Regulation 31(4) of SEBI SAST Regulations, 2011, which requires promoters to disclose any pledge or encumbrance created on their shares. The filing also confirms that no other promoter or person acting in concert created, invoked, or released any encumbrance on the company's shares during the financial year ended March 31, 2026.
Pledge creation by a promoter can signal potential risk of share dilution if the pledged shares are invoked, which could impact stock sentiment. However, this is a routine regulatory disclosure and does not by itself indicate any negative development.